Lenalidomide/Revlimid Dose-Brand name or Equal 36C25226Q0097_1
Summary
AI-generated · Nov 18, 2025A Sources Sought / RFI is issued to gather information from capable vendors to supply Lenalidomide (brand-name Revlimid) dose or an approved equal for the Pharmacy Department. This is for planning and market research only, not a solicitation, and it seeks to determine interest and capability from both Small and Other-than-Small businesses (including VIP-verified VOSB and SDVOSB) to provide a brand-name dose or an equivalent product. Details are in the attached document titled "P02_Sources Sought Notice_36C25226Q0097 - Lenalidomide-Brand Name or Equal."
Responses should address pricing, delivery, capabilities, and market availability and are requested by email to the designated contact. Information provided may be used to assess potential procurement options; responses will not constitute an offer or form a contract. Respondents must be registered in SAM and have current Online Representations and Certifications on file to be eligible.
THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. This Sources Sought Notice is for informational and planning purposes only and shall not be construed as a solicitation or as an obligation or commitment by the Government at this time. This notice is intended strictly for market research. The purpose of this Sources Sought notice is to determine interest and capability of Other than Small Businesses and Small Businesses, including VIP-Verified Veteran-Owned Small Business (VOSB) or Service-Disabled Veteran-Owned Small Business (SDVOSB) prospective vendors relative to the North American Industry Classification System (NAICS) Code 325412 (Pharmaceutical Preparation Manufacturing) and the SBA size standard is 1,300 employees. PSC Code is 6505- Drugs and Biologicals. Potential Offerors must be registered in the System for Award Management (SAM) to be eligible for an award at: https://sam.gov/content/home. Potential Offerors must also have a current Online Representations and Certification Application on file with SAM. The Department of Veteran Affairs, Jesse Brown VA Medical Center, 820 South Damen Avenue, Chicago, IL 60612-4223 has the requirement need for a Lenalidomide, or Revlimid Dose-Brand name or Equal for the Pharmacy Dept. The Government is requesting that Other Than Small Businesses and Small Businesses, including VIP-Verified VOSB or SDVOSB sources respond if it can provide the following products on a Brand Name Only (Lenalidomide, or Revlimid Dose) . Please see the attached word document file called, "P02_Sources Sought Notice_36C25226Q0097 - Lenalidomide-Brand Name or Equal" for more details/information. Responses due are to be submitted by e-mail only to: arneil.genus@va.gov. The information requested must be received no later than Thursday, November 20, 2025, 3:00 PM CST.
From Sources Sought posted on Nov 17, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA